参考文献/References:
[1] Fairhurst AM,Wandstrat AE,Wakeland EK. Systemic lupus erythematosus: multiple immunologic phenotypes in a complex genetic disease [J].Adv Immunol, 2006,92:1-69.
[2] Tsokos GC,Kammer GM.Molecular aberrations in human systemic lupus erythematosus [J].Mol Med Today, 2000,6:418-424.
[3] C’imbaluk D,Naumann A. Renal involvement in systemic lupus erythematosus : glomerular pathology,classification,and future directions \[J \]. Diagnostic Histopathology,2017, 23(3 ):109-116.
[4] Plantinga IC,Drenkard CC,Pastan SO,et al. Attribution of cause of end-stage renal disease among patients with systemiclupus erythem atosus: the georgia iup us registry [J]. Iupus Sci Med,2016,3(1):e 000132.
[5] 佚 名.系统性红斑狼疮诊断及治疗指南[J].中华风湿病学杂志,2010,14 (5 ):342-346.
[6] 杨朝晖,粱 晶,朱秋玲,等.系统性红斑狼疮患者高尿酸血症与病情的关系[J].内蒙古民族大学学报:自然科学版,2015,2:145-148.
[7] 付 豆,丁国华,王惠明,等.血尿酸水平与系统性红斑狼疮活动度及其肾损害的关系[J].山东医药,2017,57(5):43-45.
[8] 陈 宪,周 蕾,庞 杰,等.血尿酸与系统性红斑狼疮患者肾损害的关系[J].天津医科大学学报,2014,20(1):42-44.
[9] 田新玮,游碧荣,陈 昶.益气利阴活血方联合醋酸泼尼松治疗系统性红斑狼疮58例[J].陕西中医,2016,37(12):1628-1629.
[10] 郑 杰,赵亚妮,陈庆平,等.血清IFN-a、IL-6水平与系统性红斑狼疮和实验室指标相关性分析[J].陕西医学杂志,2016,45(3):366-367.
相似文献/References:
[1]全 瑛,贺唯唯,张进安,等.系统性红斑狼疮伴发亚临床动脉粥样硬化相关因素研究*[J].陕西医学杂志,2018,(12):1525.
Quan Ying,He Weiwei,Zhang Jinan,et al.Analysis of related factors for subclinical atherosclerosis in systemic lupus erythematosus[J].,2018,(7):1525.